As our new Legal Director, Capital Markets, you will be responsible for providing legal advice and support in various aspects of capital markets. You will work closely with Zealand management, internal stakeholders, and external parties to ensure compliance with regulatory requirements, negotiate and draft relevant transactional documents, mitigate legal risks associated with capital markets activities and deal with the Danish Financial Services Authority and take ownership of Zealand’s Market Abuse Regulation (MAR) responsibilities.

This role requires a deep understanding of securities laws, financial regulations, and market practices in Denmark. You will report to the General Counsel.

The role is a newly created position in our legal department and will have a one lawyer reporting to it. If you are motivated by the opportunity to establish Capital Markets as an independent area, then keep reading.

Responsibilities:

Capital Markets Transaction Structuring: Assist in structuring and executing capital markets transactions, including potential offerings, debt offerings, equity offerings, and other securities related transactions.

Legal Due Diligence: Conduct comprehensive legal due diligence on securities offerings, including reviewing disclosure documents, financial statements, and regulatory filings to ensure compliance with applicable laws and regulations in Denmark and the European Union.

Regulatory Compliance: Stay abreast of changes in securities laws and regulations and provide guidance to clients and internal stakeholders on compliance issues related to capital markets activities.

Document Drafting and Negotiation: Draft and negotiate transactional documents, including underwriting agreements, purchase agreements, prospectuses, and offering memoranda.

Client Advisory: Provide legal advice and strategic guidance to clients on a wide range of capital markets matters, including corporate governance, shareholder rights, and disclosure obligations.

Risk Management: Identify and assess legal risks associated with capital markets transactions and develop strategies to mitigate such risks. Function as a point of contact and leader of the Zealand disclosure committee.

Collaboration: Collaborate with internal teams, including investment bankers, corporate finance professionals, investor relations and compliance officers, to facilitate seamless execution of capital markets transactions.

Relationship Management: Build and maintain strong relationships with clients, including Zealand’s Management, Zealand’s Board, Zealand’s investor relations, shareholders, proxy advisors, regulators, and external counsel to support efforts and enhance and explain the firm's reputation in the market.

Management of Annual Reporting and Annual General Meetings: Direct responsibility for and management of shareholder interaction during the Annual Reporting and Annual General Meeting Process. Management and oversight of Proxy Solicitors and Computershare. Management of the Annual General Meeting and the Annual Reporting Obligations.

Candidate Profile:

Education: A Law Degree from an accredited law school. Admission to the bar in the relevant jurisdiction is required.

Experience: At least 5 years of experience practicing law in the field of capital markets, preferably with a reputable law firm or financial institution. Experience with securities offerings, DFSA regulations, and corporate governance matters is highly desirable.

Team Player: Provide leadership and mentoring to a direct report, engage in stakeholder management internally and externally. Enhance and build on Zealand’s unique culture.

Legal Expertise: In-depth knowledge of securities laws, regulations, and market practices. Strong understanding of financial instruments, including equities.

Analytical Skills: Excellent analytical and critical thinking skills with the ability to assess complex legal issues and develop practical solutions.

Communication: Exceptional written and verbal communication skills, with the ability to articulate complex legal concepts clearly and effectively to clients and stakeholders.

Collaborator: Proven ability to work collaboratively in a fast-paced, dynamic environment, both independently and as part of a team.

Attention to Detail: Meticulous attention to detail and a commitment to delivering high-quality work products within tight deadlines.

Ethical Standards: Strong ethical compass and commitment to upholding the highest standards of professional integrity and confidentiality.

Adaptability: Flexibility and adaptability to navigate evolving regulatory landscapes and market conditions.

Bonding to innovate. ​

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise. ​

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.​

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.​

Let’s bond and be bold

We offer a combined compensation package which includes a base salary, pension, bonus, and an attractive employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.

To find out more about working at Zealand, visit our career site.

Interested? Please apply as soon as possible and no later than September 25, 2024. The applications will be reviewed as they come in.

For further information, please contact Steven Turkington-Hansen on sturkingtonhansen@zealandpharma.com

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.